Filter
130
Filtered Results: 130
Text search:
Unitaid
(Innovation
in
Global
Health)
Featured
Recommendations
18
New Publications
31
Language
Document type
No document type
57
Studies & Reports
34
Guidelines
21
Strategic & Response Plan
12
Manuals
4
Brochures
1
Fact sheets
1
Countries / Regions
Global
11
Africa
5
Uganda
3
Eastern Europe
3
India
3
Mozambique
2
Asia
2
Western and Central Europe
2
Ethiopia
2
Nepal
1
Kenya
1
Nigeria
1
Germany
1
Middle East and North Africa
1
Liberia
1
Authors & Publishers
Publication Years
Category
HIV & STI
6
Communicable Diseases
3
Hepatitis
3
Virology
3
Pediatrics
3
Policies & Guidelines HIV & TB
3
Policies
3
Statistics
3
Malaria
3
Drugs & Medical Equipment
2
Studies & Reports
2
Maternal Health
2
Parasitology
2
Disease Prevention & Control
2
Global Health
2
Paediatrics
1
Humanitarian Aid
1
Cancer
1
Community Health
1
Palliative Care
1
Cervical Cancer
1
Infection Control & Prevention (IPC)
1
Public Health
1
Countries
1
Health System Strengthening
1
Medical Devices & Equipment
1
Women & Child Health
1
Community Health
1
Capacity Building
1
Palliative Care
1
Other
1
Surgery & Anaesthesia
1
Communicable Diseases
1
Health Systems
1
Primary Health Care
1
Age & Elderly
1
Reproductive Health
1
Pharmacy & Technologies
1
TB
1
Toolboxes
HIV testing & services
16
Health Financing Toolbox
8
General Reports
6
Policies
6
General Information & Methodology
5
Treatment & Prevention
4
Prevention & Control
4
Universal Health Coverage UHC and 90-90-90 Strategy
4
Research & Access
4
Reports & Studies Children HIV
4
Children
3
International
3
Essential Medicines
3
Antiretroviral Treatment ART
3
Reports & Studies
3
Policies & Strategies
2
ART Drug Resistance
2
Childhood TB
2
Clinical Aspects, Treatment & Prevention
2
Clinical Aspects
2
Children & Adolescents
2
Treatment Guidelines HIV
2
Global
2
Reports
2
Sustainable Development Goals
2
Studies
2
Access & Strategy
2
Fair Allocation & Ethical Aspects
2
COVAX Initiative
2
Prices and Patents
2
Drug resistant TB
2
Human Rights & the Right to Health
2
Testing Guidelines
2
Global Health Financing
2
Universal Health Coverage & Primary Health Care
2
SEAR (South-east Asia Region)
2
HIV support organizations
1
Azerbaijan
1
Vaccines & Immunization
1
Policies & Programmes
1
Concepts of Global Health
1
Sexually Transmitted Infections
1
Prevention & Preparedness
1
General
1
Appeals and Response Plans
1
Global Impact: Socio-economic, health services, TB & HIV
1
HIV and COVID-19
1
COVID-19
1
Advocacy & Communication
1
Overview
1
General Guidelines for Rational Use
1
Pharmaceutical Dosage Forms
1
Access to treatment and laboratory
1
General Information
1
Global Overview
1
Detection & Diagnosis
1
Disease Prevention & Control
1
TB/HIV Global
1
HIV / AIDS
1
Global Health Institutions and Stakeholders
1
Epidemiology
1
Eastern Europe & Central Asia
1
Eastern Europe and central Asia
1
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
First WHO Global Ministerial Conference
Ending TB in the Sustainable Development Era: A Multisectoral Response
Moscow, Russian Federation, 16-17 November 2017
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.
According to WHO’s latest World malaria report, there were an estimated 241 million malaria cases and 627 000 malaria deaths worldwide i...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up international coordination and support; scaling up co...
The KMC implementation strategy targets a broad audience. These include policy-makers and programme managers at national, regional and local levels, government and nongovernmental organizations working in the area of maternal and newborn care, global and national professional associations, public an...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The COVID-19 pandemic has exposed the inadequacy of investments in public health, the persistence of profound economic and social inequalities and the fragility of many key global systems and approaches.
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic...
An historic opportunity to end AIDS as a public health threat by 2030 and launch a new era of sustainability
A decade of progress has inspired the once unthinkable—that the AIDS epidemic can be ended as a public health threat. The global community has embraced the bold idea to end the AIDS ep...
A decade of progress has inspired the once unthinkable—that the AIDS epidemic can be ended as a public health threat. The global community has embraced the bold idea to end the AIDS ep...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
Wir haben die Chance, die Welt von diesen drei Krankheiten zu befreien – Krankheiten, die zum Tod
von Millionen von Menschen und zur Auflösung von Gemeinschaften auf allen Kontinenten geführt haben.
Wir haben die Chance, einen wichtigen Schritt nach vorn zu gehen – einen Schritt in Richtung ...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
